Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and Memory reports a new way to treat pathology and symptoms of fragile X syndrome, ...

Stifel lowered the firm’s price target on Astrana Health (ASTH) to $56 from $70 and keeps a Buy rating on the shares ahead of Astrana reporting ...